SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates K and PIRS on Behalf of Shareholders

Group 1 - Halper Sadeh LLC is investigating Kellanova's sale to Mars, Incorporated for $83.50 per share in cash for potential violations of federal securities laws and breaches of fiduciary duties to shareholders [1] - Pieris Pharmaceuticals' merger with Palvella Therapeutics is noted, with pre-merger Pieris shareholders expected to own approximately 18% of the combined company [2] - The firm may seek increased consideration for shareholders, additional disclosures, and other relief on behalf of shareholders [3] Group 2 - Shareholders are encouraged to contact Halper Sadeh LLC to discuss their legal rights and options at no charge [4] - Halper Sadeh LLC represents investors globally who have experienced securities fraud and corporate misconduct, recovering millions for defrauded investors [4]